Clinical Trial

Ferric Sulfate and Sodium Hypochlorite Pulpotomies in Vital Primary Teeth

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to compare the clinical and radiographic success of two commonly used pulpotomy agents, ferric sulfate (FS) and sodium hypochlorite (NaOCl), in vital primary molars. Pulpotomy is a widely used vital pulp therapy procedure in pediatric dentistry to preserve primary teeth until their natural exfoliation. The study will include children aged 4-9 years who previously received pulpotomy treatment using either FS or NaOCl at Marmara University Faculty of Dentistry. No additional treatment will be performed as part of this study. Patients will be followed during routine clinical visits at 6, 12, and 24 months. Clinical outcomes such as pain, mobility, and infection, as well as radiographic findings including resorption and radiolucency, will be evaluated. The results of this study are expected to provide evidence for the effectiveness of these materials and support clinical decision-making in pediatric dental practice.
Trial Details
NCT Number NCT07548008
Lead Sponsor Marmara University
Conditions Dental Caries, Pulpotomies Primary Teeth
Enrollment 56 participants
Start Date 2025-08-10
Primary Completion 2027-02-10 (estimated)
Study Completion 2027-02-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-23